Literature DB >> 4673141

Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.

J A Nelson, R E Parks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4673141

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  3 in total

1.  Interference of 6-mercaptopurine riboside, 6-methylmercaptopurine riboside and azathioprine with the morphogenetic differentiation of mouse extremities in vivo and in organ culture.

Authors:  D Neubert; U Lessmöllmann; N Hinz; I Dillmann; G Fuchs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

2.  Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.

Authors:  M P Sullivan; J A Nelson; S Feldman; B Van Nguyen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.

Authors:  R J Gay; H Amos
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.